Home › Thyroid Cancer › Tennessee › Memphis
Thyroid Cancer clinical trials in Memphis, TN
4 studies for Thyroid Cancer are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
RecruitingPhase 2
- St. Jude Children's Research Hospital, Memphis
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- Baptist Memorial Hospital Baptist Cancer Center, Memphis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
- Baptist (BHMCC), Memphis
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
RecruitingPhase 2
- St. Jude Children's Research Hospital, Memphis
About Thyroid Cancer
Your thyroid is a butterfly-shaped gland in your neck. There are several thyroid cancer types with different treatments. Discover options available.
More about Thyroid Cancer on MedlinePlus
Thyroid Cancer trials in other cities
- Houston, TX12 studies
- Washington, DC10 studies
- New York City, NY9 studies
- Boston, MA6 studies
- Philadelphia, PA6 studies
- Los Angeles, CA5 studies
- Durham, NC5 studies
- Nashville, TN5 studies
- San Francisco, CA4 studies
- St. Louis, MO4 studies
- San Antonio, TX4 studies
- Minneapolis, MN4 studies
Other studies in Memphis
- Cancer (all types)31 studies
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer22 studies
- Lung Cancer18 studies
- Sickle Cell Disease18 studies
- Acute Lymphoblastic Leukemia16 studies
- Acute Myeloid Leukemia15 studies
- Heart Failure13 studies
- Colorectal Cancer11 studies
- Soft Tissue Sarcoma11 studies
- Melanoma11 studies
- Prostate Cancer11 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.